新華醫療(600587.SH)子公司擬與國欣頤養集團共同設立融資租賃公司
格隆匯1月11日丨新華醫療(600587.SH)公佈,國欣頤養集團已推動實施山東省屬企業醫養健康資產重組整合工作,新華醫療擬依託國欣頤養集團擁有的醫療資源,促進公司醫療設備的銷售,出於共同發展的目的,公司擬通過全資子公司華佗國際與國欣頤養集團共同出資設立國欣頤養融資租賃公司,融資租賃公司註冊資本為2億元,其中國欣頤養集團出資1.5億元,持股比例為75%;華佗國際出資5000萬元,持股比例為25%。
華佗國際參與成立融資租賃公司,開展醫療設備、康養設備、適老化設備等業務融資租賃,可為信用級別高、發展前景好、資金壓力相對較大的醫院、製藥廠等客户提供融資租賃服務,從而促進公司醫療設備的銷售,擴大經營規模。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.